TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Clover Biopharmaceuticals Ltd. ( (HK:2197) ) is now available.
Clover Biopharmaceuticals Ltd. announced changes to its board of directors and committee memberships, effective July 1, 2025. Dr. Donna Marie Ambrosino and Mr. Xiang Liao have been appointed as members of the Nomination Committee, reflecting the company’s ongoing efforts to strengthen its governance structure.
More about Clover Biopharmaceuticals Ltd.
Clover Biopharmaceuticals Ltd. is a company incorporated in the Cayman Islands, focusing on the biopharmaceutical industry. It is involved in the development and commercialization of innovative vaccines and biologic therapeutic products.
Average Trading Volume: 1,252,715
Technical Sentiment Signal: Hold
Current Market Cap: HK$376.1M
Find detailed analytics on 2197 stock on TipRanks’ Stock Analysis page.